In vitro evaluation of the interaction between methanol extract of lichen (Ramalina farinacea) and tetracycline against clinical isolates of Staphylococcus aureus

African Journal of Biotechnology

Volumn 10, Issue 12, 2011, Pages 2314-2318

  Agboke, Akeem ^a   Jackson, Clement ^a   Adedokun, Musiliu ^b   Momoh, M A ^c  

^a UNIVERSITY OF UYO   (Nigeria)

^b OLABISI ONABANJO UNIVERSITY   (Nigeria)

^c UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Antimicrobial; Checkerboard; Combination ratio; Minimum inhibitory concentration; Strains

Indexed keywords

ANTIINFECTIVE AGENT; PLANT EXTRACT; RAMALINA FARINACEA EXTRACT; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENTIATION; IN VITRO STUDY; LICHENS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAMALINA FARINACEA; STAPHYLOCOCCUS AUREUS;

RAMALINA FARINACEA; STAPHYLOCOCCUS AUREUS;

EID: 79953116429     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Berdy J (1982). Handbook of Antibiotic Compounds. Vol. VIII Part 1: Antibiotics from Higher forms of life: Higher Plants. CRC Press, Boca Raton.
2. Cheij R (1988). The McDonald Encyclopedia of Medicinal Plants. Mcdonald & Co. Ltd., London. pp. 54-59.
3. Chinwuba GN, Chiori GO, Ghobashy AA, Okoro VC (1994). Determination of synergy of Antibiotic combination by overlay inoculum susceptibility disc method, Arzneimittel for schung\drug research, 41: 148-150.
4. Ebirim GC, Ofoefule SI (1997). Investigations into the Folkloric antimicrobial activities of Landolphia, Owrrience. Plytother. Res. II: 149-151.
5. Esimone CO, Adikwu MU, Uzuegbu DB, Udeogaranya PO (1999). The effect of ethylenediaminetetraacetic acid on the antimicrobial properties of Benzoic acid and cetrimide J. Pharm. Res. Dev. 4(1): 1-8.
6. Keele J, DeLallo VC, Lewis RE, Ernest EJ, Klepser ME (2001). Evaluation of time kill methodology. Amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using Diagn. Microbiol. Infect. Dis. 41: 121-126.
7. Lewis RE, Klepser ME (1999). The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapy. Am. J. Health Syst. Pharm. 56: 525-533.
8. Odds FC, Rinaldi MG, Sheehan DJ, Warnock DW (2001). Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14: 643-658.
9. Prea S, Gonzalez G, Fothergill AW, Sutton DA, Rinaldi MG (2002). In vitro, against clinical isolates of Candida glabrata with decreased susceptibility to azoles. J. Clin. Microbiol. 40:1831-1833.
10. Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, Gosey LL, Odds FC, Rinaldi MG, Sheehan DJ, Warnock DW (2001). Antifungal susceptibility testing practical aspects and current challenges. Clin. Microbiol. Rev. 14: 643-658.